Managing Endometrial Cancer: The Role of Pelvic Lymphadenectomy and Secondary Surgery

[1] Colombo N(2013)Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 Suppl 6 vi33-vi38

[2] Preti E(2009)Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 103-104

[3] Landoni F(2011)Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d’Oncologie Gynécologique Int J Gynecol Cancer 21 945-950

[4] Carinelli S(2010)Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 v41-v45

[5] Colombo A(2002)Standards, options and recommendations 2000: non metastatic endometrial cancer Bull Cancer 89 697-706

[6] Marini C(1992)Proposed classification of complications of surgery with examples of utility in cholecystectomy Surgery 111 518-526

[7] Pecorelli S(2008)Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 1707-1716

[8] Querleu D(2012)Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer Gynecol Oncol 127 5-10

[9] Planchamp F(2009)Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 125-136

[10] Narducci F(2000)Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182 1506-1519

[1] Colombo N(2013)Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 Suppl 6 vi33-vi38

[2] Preti E(2009)Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 103-104

[3] Landoni F(2011)Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d’Oncologie Gynécologique Int J Gynecol Cancer 21 945-950

[4] Carinelli S(2010)Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 v41-v45

[5] Colombo A(2002)Standards, options and recommendations 2000: non metastatic endometrial cancer Bull Cancer 89 697-706

[6] Marini C(1992)Proposed classification of complications of surgery with examples of utility in cholecystectomy Surgery 111 518-526

[7] Pecorelli S(2008)Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 1707-1716

[8] Querleu D(2012)Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer Gynecol Oncol 127 5-10

[9] Planchamp F(2009)Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 125-136

[10] Narducci F(2000)Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182 1506-1519